Vericel Corporation (VCEL) is a leader in the field of advanced therapies for the sports medicine and severe burn care markets. This Nasdaq-listed company is at the forefront of developing cell therapies that enhance the body's inherent ability to heal.
Headquartered in Cambridge, Massachusetts, Vericel was established over three decades ago in 1989. The company specializes in autologous cell therapies — a method that involves using a patient's cells to generate a treatment for their medical condition, leveraging the natural healing capabilities of human cells.
Since inception, Vericel has been committed to the development and commercialization of innovative therapies for patients with serious diseases and conditions. The company boasts two marketed products that cater to orthopedics and burn care: MACI (autologous cultured chondrocytes on porcine collagen membrane) for cartilage repair and Epicel (cultured epidermal autografts) for treating severe burns.
MACI was the first FDA-approved product that encourages regrowth of knee cartilage using a patient's cells. The regenerative potential of MACI has helped countless patients restore mobility and return to an active lifestyle. Epicel, on the other hand, is a pivotal solution for patients who suffer from severe burns. It is a life-saving graft capable of covering large burn areas using a small piece of the patient’s skin.
Vericel's devotion to improving the lives of patients is reflected in its commitment to research and development. The company maintains a robust pipeline and is currently developing more treatments for acute respiratory distress syndrome and other severe manifestations of immune response.
With a team of over 200 employees, Vericel is recognized for its exceptional contribution in the field of regenerative medicine. It is equipped with a purpose-built, in-house manufacturing facility that fulfills the complicated process of harvesting, processing, and delivering cell therapies to healthcare providers.
Despite the challenges, Vericel faces - regulatory complexities, production issues, or market acceptance - the company continues to foster innovation, and remain focused on delivering significant health care benefits to improve patients’ lives. This unwavering commitment to break new ground in medical therapies has made Vericel a trusted name in the field of regenerative medicine. Vericel Corporation not only highlights the advancements in the medical field but also emphasizes the power of innovative therapies to change lives for the better.